Contact Us
Biopharmaceutical Third-Party Logistics Global Market Report 2025
Global Biopharmaceutical Third-Party Logistics Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Biopharmaceutical Third-Party Logistics Global Market Report 2025

By Supply Chain (Cold Chain, Non-Cold Chain), By Service (Transportation, Warehousing And Storage, Other Services), By End-User (Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Hospitals And Clinics, Other End-Users ) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Biopharmaceutical Third-Party Logistics Market Overview

• Biopharmaceutical Third-Party Logistics market size has reached to $141.59 billion in 2024

• Expected to grow to $203.18 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%

• Growth Driver: Outsourcing Logistics Drives Growth In Biopharmaceutical 3Pl Market

• Market Trend: Strategic Product Launches Drive Competitiveness In The Market

North America was the largest region in 2024.

What Is Covered Under Biopharmaceutical Third-Party Logistics Market?

Biopharmaceutical third-party logistics refers to a partner or service that helps in the provision of logistics services by external entities to pharmaceutical companies. These companies delegate their transportation needs to third-party providers to minimize costs, and the absence of in-house capabilities is a significant factor driving the expansion of transportation outsourcing.

The main types of biopharmaceutical third-party logistics supply chains are cold chain and non-cold chain. The cold chain refers to a supply chain that maintains temperature control throughout the transportation of temperature-sensitive products. the various services are transportation, warehousing and storage, and others used by pharmaceutical and biopharmaceutical companies, medical device companies, hospitals and clinics, and others.

Biopharmaceutical Third-Party Logistics Market Size and growth rate 2025 to 2029: Graph

What Is The Biopharmaceutical Third-Party Logistics Market Size 2025 And Growth Rate?

The biopharmaceutical third-party logistics market size has grown strongly in recent years. It will grow from $141.59 billion in 2024 to $150.5 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to globalization of pharma supply chains, stringent regulatory requirements, rise in biopharmaceuticals, focus on cold chain logistics

What Is The Biopharmaceutical Third-Party Logistics Market Growth Forecast?

The biopharmaceutical third-party logistics market size is expected to see strong growth in the next few years. It will grow to $203.18 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to personalized medicine growth, biologics and biosimilars expansion, supply chain digitalization, regulatory compliance complexity, COVID-19 impact. Major trends in the forecast period include on-demand logistics solutions, sustainability in logistics, last-mile delivery solutions, pharma serialization and traceability, autonomous logistics.

The forecast of 7.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. drug distribution by inflating prices of temperature-controlled shipping solutions and track-and-trace systems developed in Germany and the Netherlands, resulting in compromised cold chain integrity and higher logistics costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Biopharmaceutical Third-Party Logistics Market Segmented?

1) By Supply Chain: Cold Chain, Non-Cold Chain

2) By Service: Transportation, Warehousing And Storage, Other Services

3) By End-User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Hospitals And Clinics, Other End-Users

Subsegments:

1) By Cold Chain: Refrigerated Transport, Temperature-Controlled Storage, Specialized Packaging

2) By Non-Cold Chain: Ambient Transport, Standard Storage Solutions, General Packaging Methods

What Is Driving The Biopharmaceutical Third-Party Logistics Market? Outsourcing Logistics Drives Growth In Biopharmaceutical 3Pl Market

The rising trend of outsourcing logistics is expected to drive the growth of the biopharmaceutical third-party logistics market. Outsourcing logistics involves engaging a third party to handle all or a portion of a company's logistical activities. Outsourcing logistics is used in biopharmaceutical third-party logistics for outsourcing cryogenic supply chain management to logistics partners. For instance, in February 2024, according to the Bureau of Transportation Statistics, a US-based part of the Department of Transportation (DOT), for-hire freight shipments rose by 1.8% in December 2023 compared to December 2022, while the Freight Transportation Services Index increased from 136.6 in December 2022 to 139.1 in December 2023. Therefore, the rising trend of outsourcing logistics is expected to propel the growth of the biopharmaceutical third-party logistics industry.

What Is Driving The Biopharmaceutical Third-Party Logistics Market? Driving Growth In Biopharmaceutical Third-Party Logistics

The launch of innovative biopharmaceutical products is expected to drive the growth of the biopharmaceutical third-party logistics market. Innovative biopharmaceutical products refer to advanced and novel therapeutic substances derived from biological sources, such as monoclonal antibodies or gene therapies. The biopharmaceutical third-party logistics market plays a crucial role in the efficient launch of these products by providing streamlined supply chain solutions, ensuring timely and secure distribution, and supporting the complex logistics involved in bringing these innovative therapies to market. For instance, in January 2024, according to the New Drug Therapy Approvals 2023 report published by the Center for Drug Evaluation and Research (CDER), a US-based branch of the U.S. Food and Drug Administration (FDA), the CDER approved 55 novel drugs in 2023, with 20 (36%) identified as first-in-class, compared to 37 novel drug approvals in 2022. Therefore, the launch of innovative biopharmaceutical products is expected to propel the growth of the biopharmaceutical third-party logistics industry.

Who Are The Major Players In The Global Biopharmaceutical Third-Party Logistics Market?

Major companies operating in the biopharmaceutical third-party logistics market include McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, Catalent Inc., Almac Group, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics, PCI Pharma Services

What Are The Key Trends Of The Global Biopharmaceutical Third-Party Logistics Market? Strategic Product Launches Drive Competitiveness In The Market

Technological advancements are a key trend gaining popularity in the biopharmaceutical third-party logistics market. Major companies operating in the biopharmaceutical third-party logistics market are focused on launching new products to strengthen their position and gain a competitive advantage. For instance, in November 2022, Celcius Logistics Solutions Pvt Ltd., an India-based provider of logistics services, launched Hyper-Local temperature-controlled delivery services for food and pharma orders. The company offers its last-mile solution, which includes a service suitable for smaller quantities. This service is available in nine cities throughout the country. By implementing a hyperlocal approach, the company guarantees the optimal quality of transported materials by continuously monitoring temperature in real time at each stage of the delivery process.

What Are The Key Trends Of The Global Biopharmaceutical Third-Party Logistics Market? Companies Are Expanding Logistics Capabilities For Efficient Healthcare Product Management

Major companies operating in the biopharmaceutical third-party logistics market are focusing on innovative solutions such as business expansion in life sciences and healthcare logistics to enhance logistics capabilities for pharmaceutical and healthcare products, ensuring efficient storage and distribution. Business expansion in life sciences and healthcare logistics refers to the strategic growth of logistics companies to enhance their capabilities in transporting and managing medical products, which is crucial for ensuring timely delivery and maintaining the integrity of temperature-sensitive items essential for patient care. For instance, in August 2022, DHL Supply Chain, a Germany-based contract logistics specialist of Deutsche Post DHL Group, announced the expansion of its Life Sciences and Healthcare Campus in Florstadt, Germany. This expansion includes the construction of a new logistics center that adds 32,000 square meters of space dedicated to the storage and distribution of pharmaceutical and medical products. The facility will feature various temperature-controlled zones and has the capacity for 10,000 pallet locations, allowing it to handle a wide range of pharmaceutical products. This move aims to enhance DHL's capabilities in pharmaceutical logistics and support the growing demands of the healthcare sector, ensuring efficient and compliant handling of sensitive medical supplies.

Need data on a specific region in this market?

Biopharmaceutical Third-Party Logistics Market Merger And Acquisition: Stg Logistics' Acquisition Of Xpo's Intermodal Business

In March 2022, STG Logistics Inc., a US-based provider of optimized logistics and transportation services, acquired the intermodal division of XPO Logistics Inc. for $710 million. The acquisition of XPO Logistics' intermodal division by STG Logistics bolsters its prominent role in containerized logistics. Through this acquisition, STG Logistics is now well positioned for further achievements in the containerized logistics industry. XPO Logistics Inc. is a US-based provider of asset-based less-than-truckload (LTL) freight transportation and third-party logistics, including biopharma logistic.

Regional Outlook For The Global Biopharmaceutical Third-Party Logistics Market

North America was the largest region in the biopharmaceutical third party logistics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Biopharmaceutical Third-Party Logistics Market?

The biopharmaceutical third-party logistics market consists of revenues earned by entities by providing biopharmaceutical third-party logistics such as domestic transportation management, international transportation management, and value-added warehousing and distribution. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Biopharmaceutical Third-Party Logistics Industry?

The biopharmaceutical third-party logistics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical third-party logistics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Biopharmaceutical Third-Party Logistics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $150.5 billion
Revenue Forecast In 2034 $203.18 billion
Growth Rate CAGR of 7.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Supply Chain: Cold Chain, Non-Cold Chain
2) By Service: Transportation, Warehousing And Storage, Other Services
3) By End-User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Hospitals And Clinics, Other End-Users Subsegments: 1) By Cold Chain: Refrigerated Transport, Temperature-Controlled Storage, Specialized Packaging
2) By Non-Cold Chain: Ambient Transport, Standard Storage Solutions, General Packaging Methods
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, Catalent Inc., Almac Group, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics, PCI Pharma Services
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Biopharmaceutical Third-Party Logistics Market Characteristics

3. Biopharmaceutical Third-Party Logistics Market Trends And Strategies

4. Biopharmaceutical Third-Party Logistics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biopharmaceutical Third-Party Logistics Growth Analysis And Strategic Analysis Framework

5.1. Global Biopharmaceutical Third-Party Logistics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Biopharmaceutical Third-Party Logistics Market Growth Rate Analysis

5.4. Global Biopharmaceutical Third-Party Logistics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Biopharmaceutical Third-Party Logistics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Biopharmaceutical Third-Party Logistics Total Addressable Market (TAM)

6. Biopharmaceutical Third-Party Logistics Market Segmentation

6.1. Global Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cold Chain

Non-Cold Chain

6.2. Global Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Transportation

Warehousing And Storage

Other Services

6.3. Global Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical And Biopharmaceutical Companies

Medical Device Companies

Hospitals And Clinics

Other End-Users

6.4. Global Biopharmaceutical Third-Party Logistics Market, Sub-Segmentation Of Cold Chain, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Refrigerated Transport

Temperature-Controlled Storage

Specialized Packaging

6.5. Global Biopharmaceutical Third-Party Logistics Market, Sub-Segmentation Of Non-Cold Chain, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ambient Transport

Standard Storage Solutions

General Packaging Methods

7. Biopharmaceutical Third-Party Logistics Market Regional And Country Analysis

7.1. Global Biopharmaceutical Third-Party Logistics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Biopharmaceutical Third-Party Logistics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biopharmaceutical Third-Party Logistics Market

8.1. Asia-Pacific Biopharmaceutical Third-Party Logistics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biopharmaceutical Third-Party Logistics Market

9.1. China Biopharmaceutical Third-Party Logistics Market Overview

9.2. China Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biopharmaceutical Third-Party Logistics Market

10.1. India Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biopharmaceutical Third-Party Logistics Market

11.1. Japan Biopharmaceutical Third-Party Logistics Market Overview

11.2. Japan Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biopharmaceutical Third-Party Logistics Market

12.1. Australia Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biopharmaceutical Third-Party Logistics Market

13.1. Indonesia Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biopharmaceutical Third-Party Logistics Market

14.1. South Korea Biopharmaceutical Third-Party Logistics Market Overview

14.2. South Korea Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biopharmaceutical Third-Party Logistics Market

15.1. Western Europe Biopharmaceutical Third-Party Logistics Market Overview

15.2. Western Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biopharmaceutical Third-Party Logistics Market

16.1. UK Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biopharmaceutical Third-Party Logistics Market

17.1. Germany Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biopharmaceutical Third-Party Logistics Market

18.1. France Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biopharmaceutical Third-Party Logistics Market

19.1. Italy Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biopharmaceutical Third-Party Logistics Market

20.1. Spain Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biopharmaceutical Third-Party Logistics Market

21.1. Eastern Europe Biopharmaceutical Third-Party Logistics Market Overview

21.2. Eastern Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biopharmaceutical Third-Party Logistics Market

22.1. Russia Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biopharmaceutical Third-Party Logistics Market

23.1. North America Biopharmaceutical Third-Party Logistics Market Overview

23.2. North America Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biopharmaceutical Third-Party Logistics Market

24.1. USA Biopharmaceutical Third-Party Logistics Market Overview

24.2. USA Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biopharmaceutical Third-Party Logistics Market

25.1. Canada Biopharmaceutical Third-Party Logistics Market Overview

25.2. Canada Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biopharmaceutical Third-Party Logistics Market

26.1. South America Biopharmaceutical Third-Party Logistics Market Overview

26.2. South America Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biopharmaceutical Third-Party Logistics Market

27.1. Brazil Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biopharmaceutical Third-Party Logistics Market

28.1. Middle East Biopharmaceutical Third-Party Logistics Market Overview

28.2. Middle East Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biopharmaceutical Third-Party Logistics Market

29.1. Africa Biopharmaceutical Third-Party Logistics Market Overview

29.2. Africa Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biopharmaceutical Third-Party Logistics Market Competitive Landscape And Company Profiles

30.1. Biopharmaceutical Third-Party Logistics Market Competitive Landscape

30.2. Biopharmaceutical Third-Party Logistics Market Company Profiles

30.2.1. McKesson Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.2. AmerisourceBergen Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.3. United Parcel Service of America Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. FedEx Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.5. DHL International GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Biopharmaceutical Third-Party Logistics Market Other Major And Innovative Companies

31.1. Kuehne + Nagel International AG

31.2. SF Express Co Ltd.

31.3. DB Schenker

31.4. CH Robinson Worldwide Inc.

31.5. Nippon Express Group

31.6. Expeditors International of Washington Inc.

31.7. Sinotrans Limited

31.8. XPO Logistics Inc.

31.9. Kerry Logistics Network Limited

31.10. Bollore Logistics

31.11. Catalent Inc.

31.12. Almac Group

31.13. VersaCold Logistics Services

31.14. Cryoport Inc.

31.15. Agility Logistics Corp

32. Global Biopharmaceutical Third-Party Logistics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biopharmaceutical Third-Party Logistics Market

34. Recent Developments In The Biopharmaceutical Third-Party Logistics Market

35. Biopharmaceutical Third-Party Logistics Market High Potential Countries, Segments and Strategies

35.1 Biopharmaceutical Third-Party Logistics Market In 2029 - Countries Offering Most New Opportunities

35.2 Biopharmaceutical Third-Party Logistics Market In 2029 - Segments Offering Most New Opportunities

35.3 Biopharmaceutical Third-Party Logistics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Biopharmaceutical Third-Party Logistics Market, Sub-Segmentation Of Cold Chain, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Biopharmaceutical Third-Party Logistics Market, Sub-Segmentation Of Non-Cold Chain, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Biopharmaceutical Third-Party Logistics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Biopharmaceutical Third-Party Logistics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: McKesson Corporation Financial Performance
  • Table 77: AmerisourceBergen Corporation Financial Performance
  • Table 78: United Parcel Service of America Inc. Financial Performance
  • Table 79: FedEx Corporation Financial Performance
  • Table 80: DHL International GmbH Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Biopharmaceutical Third-Party Logistics Market, Sub-Segmentation Of Cold Chain, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Biopharmaceutical Third-Party Logistics Market, Sub-Segmentation Of Non-Cold Chain, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Biopharmaceutical Third-Party Logistics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Biopharmaceutical Third-Party Logistics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Biopharmaceutical Third-Party Logistics Market, Segmentation By Supply Chain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Biopharmaceutical Third-Party Logistics Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Biopharmaceutical Third-Party Logistics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: McKesson Corporation Financial Performance
  • Figure 77: AmerisourceBergen Corporation Financial Performance
  • Figure 78: United Parcel Service of America Inc. Financial Performance
  • Figure 79: FedEx Corporation Financial Performance
  • Figure 80: DHL International GmbH Financial Performance

Frequently Asked Questions

Biopharmaceutical third-party logistics refers to a partner or service that helps in the provision of logistics services by external entities to pharmaceutical companies. These companies delegate their transportation needs to third-party providers to minimize costs, and the absence of in-house capabilities is a significant factor driving the expansion of transportation outsourcing. For further insights on this market, request a sample here

The market major growth driver - Outsourcing Logistics Drives Growth In Biopharmaceutical 3Pl Market. For further insights on this market, request a sample here

The biopharmaceutical third-party logistics market size has grown strongly in recent years. It will grow from $141.59 billion in 2024 to $150.5 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to globalization of pharma supply chains, stringent regulatory requirements, rise in biopharmaceuticals, focus on cold chain logistics. The biopharmaceutical third-party logistics market size is expected to see strong growth in the next few years. It will grow to " $203.18 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to personalized medicine growth, biologics and biosimilars expansion, supply chain digitalization, regulatory compliance complexity, COVID-19 impact. Major trends in the forecast period include on-demand logistics solutions, sustainability in logistics, last-mile delivery solutions, pharma serialization and traceability, autonomous logistics. For further insights on this market, request a sample here

The biopharmaceutical third-party logisticsmarket covered in this report is segmented –
1) By Supply Chain: Cold Chain; Non-Cold Chain
2) By Service: Transportation; Warehousing And Storage; Other Services
3) By End-User: Pharmaceutical And Biopharmaceutical Companies; Medical Device Companies; Hospitals And Clinics; Other End-Users Subsegments:
1) By Cold Chain: Refrigerated Transport; Temperature-Controlled Storage; Specialized Packaging
2) By Non-Cold Chain: Ambient Transport; Standard Storage Solutions; General Packaging Methods For further insights on this market,
request a sample here

North America was the largest region in the biopharmaceutical third party logistics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical third-party logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the biopharmaceutical third-party logistics market include McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, Catalent Inc., Almac Group, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics, PCI Pharma Services . For further insights on this market, request a sample here.

Major trends in this market include Strategic Product Launches Drive Competitiveness In The Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon